Cancer Science

Papers
(The H4-Index of Cancer Science is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Issue Information126
Issue Information102
Issue Information96
Issue Information92
Issue Information89
Identification of sequence polymorphism in the D‐loop region of mitochondrial DNA as a risk factor for breast cancer79
Correction to “ELF3‐AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood”78
Correction to “Expression of concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK72
Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK and endothelial nitric oxide syn68
Retraction67
Novel CHI3L1‐Associated Angiogenic Phenotypes Define Glioma Microenvironments: Insights From Multi‐Omics Integration52
Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin‐mediated ribosomal RNA synt50
PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma50
Efficacy and biomarker analysis of second‐line nab‐paclitaxel plus sintilimab in patients with advanced biliary tract cancer48
Prognostic and Predictive Value of Machine Learning‐Based Biomarker and Pathomics Signatures in Patients With Prostate Cancer48
Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL ‐4, Enhancing Tumor Growth in Hep48
A Contrast‐Enhanced Ultrasound Cine‐Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic Therapie48
Heterogeneity of Cellular Senescence: Subtype‐Specific Mechanisms and the Emerging Role of Plasma Membrane Damage46
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer:45
LHPP‐P38 MAPK/ERK‐ETS1 Axis Negative Feedback Signaling Restrains Progression in Breast Cancer43
Effectiveness and Safety of Radium‐223 for Bone‐Metastatic Castration‐Resistant Prostate Cancer: The KYUCOG ‐1901 Study43
42
Induction of immunogenic cell death in murine colon cancer cells by ferrocene‐containing redox phospholipid polymers40
Novel and efficient method for culturing patient‐derived gastric cancer stem cells40
Susceptibility of Brca1(L63X/+) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer39
Real‐World Data Analysis of Genomic Alterations Detected by a Dual DNA–RNA Comprehensive Genomic Profiling Test37
PHAX enhanced LIN28B‐mediated PBX3 mRNA stability to promote esophageal cancer development37
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system37
Methyltransferase‐like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6‐methyladenosine‐dependent manner37
A Multicenter Phase II Trial of Nimustine Hydrochloride Administered via Convection‐Enhanced Delivery in Children With DIPG37
TIFA promotes colorectal cancer cell proliferation in an RSK‐ and PRAS40‐dependent manner37
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX936
Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma36
Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders36
TGF‐β signaling promotes desmoid tumor formation via CSRP2 upregulation36
EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment36
Formin‐like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6/CKAP4/ERK axis36
0.74663114547729